Back to Treatments

Treatment

OnabotulinumtoxinA (Botox)

1
Conditions
63
Trials
9,000
Participants
65%
Average Safety

Condition Evidence

Migraine

63 trials · 9,000 participants

72% effectiveness · 65% safety
OnabotulinumtoxinA (Botox) | DFDA